Viatris VTRS 深沪

等待开盘 10-09 09:30:00 美东时间

17.44

-0.050

-0.29%

华盛通

立即下载

最高17.52
今开17.26
成交量 1410.99万股
最低 16.89
昨收 17.49
总市值 200.31亿
52周最高 18.43
市盈率 ^静 --
换手率 1.23%
52周最低 9.44
委比 5.58%
总股本 11.49亿
历史最高 18.43
量比 1.90
振幅 3.60%
历史最低 6.13
每手 1
风险率 2.59%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Pacira BioSciences shares are trading higher after the company announced it will be acquired by Viatris.

Pacira BioSciences shares are trading higher after the company announced it will be acquired by Viatris.

10-08 21:27
4 stocks to watch on Thursday: AVGO, PLTR, AMZN, and VTRS

Stock index futures slid on Thursday after oil prices rose as prospects for a peace agreement between Iran and the United States appeared difficult. Here are four stocks to watch on the day: Broadcom...

10-08 20:42
Viatris to buy Pacira BioSciences for $36.50/share in cash

Viatris (VTRS) and Pacira BioSciences (PCRX) said they entered into a definitive agreement under which Viatris will acquire all outstanding shares of Pacira for $36.50 per share in cash, representing ...

10-08 19:56
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级

今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元

10-06 16:45
UBS Maintains Buy on Viatris, Raises Price Target to $26

UBS analyst Ashwani Verma maintains Viatris (NASDAQ:VTRS) with a Buy and raises the price target from $23 to $26.

10-06 04:43
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio

Harrow Health ( ($HROW) ) has shared an announcement. On October 1, 2026, Harro...

10-05 19:57
Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026

PITTSBURGH, Oct. 5, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report third-quarter 2026 financial results on Thursday, November 5...

10-05 18:59
Harrow Closes Acquisition of TYRVAYA®

Harrow acquired TYRVAYA, the first FDA-approved nasal spray for dry eye disease (DED), expanding its ocular surface franchise. TYRVAYA, a cholinergic agonist, stimulates basal tear production via the trigeminal parasympathetic pathway and is approved in the U.S., China, and Taiwan. The acquisition includes worldwide rights except Japan, with Viatris retaining commercialization rights there. Harrow paid $30 million upfront, with up to $70 million ...

10-05 11:00
Stock index futures tick higher ahead of jobs report

Stock index futures rose before the bell as investors braced for the September nonfarm payrolls report, with economic data resilience remaining a key driver of market sentiment. Nasdaq 100 futures (US...

10-02 15:41
Teva wins biosimilar approval of Amgen's Xgeva

The US FDA approved Teva Pharmaceutical Industries' (TEVA) Degvema (denosumab-adet), a biosimilar to Amgen's (AMGN) Xgeva (denosumab), which is indicated to prevent bone damage and complications in ca...

09-29 04:57

派息除权日	每股总股息	派息日期
2026-08-21	0.12	2026-09-16
2026-05-22	0.12	2026-06-17
2026-03-09	0.12	2026-03-18
2025-11-24	0.12	2025-12-15
2025-08-22	0.12	2025-09-15
2025-05-23	0.12	2025-06-16
2025-03-10	0.12	2025-03-18
2024-11-22	0.12	2024-12-13
2024-08-23	0.12	2024-09-13
2024-05-23	0.12	2024-06-14
2024-03-08	0.12	2024-03-18
2023-11-22	0.12	2023-12-15
2023-08-23	0.12	2023-09-15
2023-05-23	0.12	2023-06-16
2023-03-08	0.12	2023-03-17
2022-11-22	0.12	2022-12-16
2022-08-23	0.12	2022-09-16
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-23	0.05	1991-07-14
1991-03-22	0.05	1991-04-14
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-24	0.05	1990-07-15
1989-12-22	0.05	1990-01-15
1989-06-25	0.05	1989-07-16
1988-12-23	0.05	1989-01-16
1988-06-28	0.05	1988-07-14
1987-12-24	0.05	1988-01-15
1987-06-23	0.05	1987-07-14
1986-12-24	0.05	1987-01-15
1986-06-23	0.05	1986-07-14
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名称	Viatris
行业分类	--
业务描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris VTRS 深 沪

17.44

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Viatris VTRS 深沪